Search Results 421-430 of 18155 for monoclonal antibody

  1. Elranatamab-bcmm (subcutaneous route) - Side effects & uses - Mayo Clinic

    These previous treatments include a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. This medicine is available only ...

  2. Potential one-time gene therapy treatment for wet age-related macular degeneration - Mayo Clinic

    ... monoclonal antibody fragment," says Dr. Bakri. "The expressed protein is designed to neutralize vascular endothelial growth factor (VEGF) activity. Anti ...

  3. Medical Research & Education - Mayo Clinic News Network

    Monoclonal antibody therapy for COVID-19 safe for transplant patients featured image. COVID-19. Monoclonal antibody therapy for COVID-19 safe for transplant ...

  4. Medical Research & Education - Mayo Clinic News Network

    Latest stories · Science Saturday: COVID-19 “Live” Virus Research In a Specialized Lab featured · Monoclonal antibody treatment can help high-risk patients with ...

  5. Clinical trials - Oncology (Medical)

    Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

  6. Medical Research & Education - Mayo Clinic News Network

    Research · Research · Monoclonal antibody treatment combo reduces hospitalization among high-risk patients with COVID-19 featured · Science Saturday: Opioids ...

  7. A Study to Test Sacituzumab Govitecan Therapy in Patients with HER2-Negative Breast Cancer and Brain Metastases - Mayo Clinic

    Sacituzumab govitecan is a monoclonal antibody, called sacituzumab, linked to a chemotherapy drug, called govitecan. Sacituzumab is a form of targeted ...

  8. Trastuzumab-dkst (intravenous route) - Side effects & uses - Mayo Clinic

    Trastuzumab-dkst is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...

  9. Linvoseltamab-gcpt (intravenous route) - Side effects & uses - Mayo Clinic

    These previous treatments include a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. This medicine is available only ...

  10. Medical Research & Education - Mayo Clinic News Network

    August 30, 2021. Monoclonal antibody treatment combo reduces hospitalization among high-risk patients with COVID-19 featured. Featured News. Monoclonal ...